Infosys Share Price: Morgan Stanley flags limited upside on US acquisitions, maintains equal‑weight rating – Check target – Markets
Morgan Stanley has taken a cautious view on Infosys’ recently announced US acquisitions of Optimum Healthcare IT and Stratus Global, maintaining an Equal‑weight rating and keeping its target price unchanged at Rs 1,760. While the deals strengthen Infosys’ footprint in the healthcare IT segment, the brokerage believes their near‑term financial impact remains modest. Infosys shares…
